ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AD02 | B | Tacrolimus monohydrate - 1mg | 7640 | 186522/13 | ADVAGRAF | 1mg | 100 | Capsule, prolonged release | Oral | Abela Frères S.A.L. | Astellas Ireland Co Ltd | Ireland | 25,729,044 L.L | 19.35 | D | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AD02 | B | Tacrolimus monohydrate - 1mg | 7640/388 | 186522/13 | ADVAGRAF | 1mg | 100 | Capsule, prolonged release | Oral | Abela Frères S.A.L. | Astellas Ireland Co Ltd | Ireland | L.L | 19.35 | D | Hikma Pharmaceuticals | Jordan | 2/5/2024 |